D. Balasus

Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells.

A. Scala, A. Mazzaglia, M. Bondì, 2015, Biomacromolecules.

Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma.

M. Soresi, M. Cervello, G. Montalto, 2011, Omics : a journal of integrative biology.

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation.

J. McCubrey, S. Strom, C. Di Sano, 2017, International journal of oncology.

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.

J. McCubrey, M. Cervello, G. Augello, 2017, Advances in biological regulation.

Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.

M. Soresi, G. Montalto, A. Licata, 2013, World journal of gastroenterology.

Nanoparticles of a polyaspartamide‐based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation

G. Pitarresi, G. Giammona, M. Cervello, 2017, Journal of controlled release : official journal of the Controlled Release Society.

The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population

M. Vinciguerra, T. Mazza, C. Fusilli, 2016, Oncotarget.